Moreover, Tan-IIA treatment repressed HCC cell viability, proliferation, invasion, and stemness, accompanied by a decrease in overall m6A levels as well as a downregulation of METTL3 protein levels, implying that Tan-IIA works by repressing METTL3 expression. Here, METTL3 is linked to hepatocellular carcinoma.